1. Home
  2. ICHR vs IVA Comparison

ICHR vs IVA Comparison

Compare ICHR & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$48.43

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$6.31

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
IVA
Founded
1999
2011
Country
United States
France
Employees
N/A
84
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ICHR
IVA
Price
$48.43
$6.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
10
Target Price
$40.67
$16.20
AVG Volume (30 Days)
1.2M
397.8K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$947,652,000.00
N/A
Revenue This Year
$16.08
N/A
Revenue Next Year
$11.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.61
N/A
52 Week Low
$13.15
$2.70
52 Week High
$55.00
$7.98

Technical Indicators

Market Signals
Indicator
ICHR
IVA
Relative Strength Index (RSI) 63.67 50.40
Support Level $15.70 $5.71
Resistance Level N/A $6.48
Average True Range (ATR) 4.08 0.29
MACD -0.32 -0.03
Stochastic Oscillator 55.63 29.86

Price Performance

Historical Comparison
ICHR
IVA

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: